Courier Capital LLC Biogen Inc. Transaction History

Courier Capital LLC

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Jul 31, 2023	SELL	$275.25 - $318.06 $66,060 - $76,334	-240 Reduced 22.73%	816 $232,000
Q1 2022 May 02, 2022	SELL	$193.77 - $244.14 $9,688 - $12,207	-50 Reduced 4.52%	1,056 $222,000
Q2 2021 Jul 12, 2021	SELL	$259.0 - $414.71 $5,180 - $8,294	-20 Reduced 1.78%	1,106 $383,000
Q3 2020 Nov 09, 2020	BUY	$264.77 - $305.71 $37,067 - $42,799	140 Added 14.2%	1,126 $366,000
Q2 2019 Jul 16, 2019	SELL	$219.29 - $241.72 $1,096 - $1,208	-5 Reduced 0.5%	986 $231,000
Q4 2018 Feb 08, 2019	SELL	$278.5 - $352.75 $13,925 - $17,637	-50 Reduced 4.8%	991 $298,000
Q3 2018 Oct 12, 2018	SELL	$293.51 - $383.83 $48,429 - $63,331	-165 Reduced 13.68%	1,041 $368,000
Q2 2018 Jul 19, 2018	BUY	$257.52 - $306.91 $11,588 - $13,810	45 Added 3.88%	1,206 $350,000
Q1 2018 Apr 27, 2018	SELL	$260.13 - $367.91 $26,013 - $36,791	-100 Reduced 7.93%	1,161 $318,000
Q4 2017 Jan 25, 2018	SELL	$307.64 - $344.58 $36,916 - $41,349	-120 Reduced 8.69%	1,261 $402,000
Q3 2017 Nov 03, 2017	SELL	$281.15 - $329.69 $75,067 - $88,027	-267 Reduced 16.2%	1,381 $432,000
Q2 2017 Aug 10, 2017	BUY	N/A	1,648	1,648 $447,000

1,018

128M

1.22M

1.4M

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $25B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

Get notified when there are updates to the investment portfolio of Courier Capital LLC, based on Form 13F filings with the SEC.

Stay updated on Courier Capital LLC with notifications on news.